Literature Review Of Drug-Receptor Interactions Based On Molecular Docking From The Perspective Of Lock And Key Theory
Article Sidebar
Main Article Content
Abstract
Drug-receptor interactions are the primary basis for determining the effectiveness of a therapy. Understanding the mechanisms of these interactions continues to evolve with advances in computational technology, one of which is through the molecular docking approach. This method enables in silico analysis of ligand-receptor interactions, including predictions of binding affinity, complex stability, and the types of molecular interactions that occur. Furthermore, the lock and key theory is a fundamental concept in explaining the structural compatibility between drugs and receptors, which influences bond strength and specificity. The method used in this review is a literature review from various scientific databases such as PubMed, Google Scholar, and ScienceDirect, with journals published in 2020 or later as inclusion criteria. The results show that oseltamivir has high affinity for neuraminidase through specific interactions such as hydrogen bonding and electrostatic binding. However, mutations in the receptor can lead to drug resistance. Therefore, understanding the mechanisms of molecular interactions is crucial for the development of more effective antiviral drugs.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Ahmad, Z., & Amin, S. (2025). Literature on the use of molecular docking in identifying potential compounds as anti-SARS-CoV-2 agents. Journal of Public Health Science (JoPHS), 2(2), 230.
Akinyede, KA, Oyewusi, HA, Hughes, GD, Ekpo, OE, & Oguntibeju, OO (2022). In vitro evaluation of the anti-diabetic potential of aqueous acetone Helichrysum petiolare extract (AAHPE) with molecular docking relevance in diabetes mellitus. Molecules, 27(1).
Amin, S., Andini, M., Alfarizi, A., & Pratomo, DW (2025). Molecular docking exploration of antiviral compounds against SARS-CoV-2 protein targets: The role of umifenovir as a therapeutic candidate in medicinal chemistry for COVID-19. Journal of Innovative and Creativity, 5(3), 17–26.
Azahra, FF, & Amin, S. (2025). Systematic analysis and bibliometric molecular docking of natural compounds as antidiabetic type 2. Journal of Public Health Science (JoPHS), 2(4), 476–484.
Biswas, S., Mahmud, S., Mita, MA, Afrose, S., Hasan, MR, Sultana Shimu, MS, Saleh, MA, Mostafa-Hedeab, G., Alqarni, M., Obaidullah, AJ, & Batiha, GES (2022). Molecular docking and dynamics studies to explore effective inhibitory peptides against the spike receptor binding domain of SARS-CoV-2. Frontiers in Molecular Biosciences, 8.
El Aissaoui, H., Zerrouk, A., & Benharref, A. (2022). Computational molecular docking and virtual screening in medicinal chemistry. Current Topics in Medicinal Chemistry, 22(14), 1172–1185.
Feunaing, M. (2024). In vitro and molecular docking evaluation of the anticholinesterase and antidiabetic effects of compounds from Terminalia macroptera.
Karuna Sugito, S., Uli Cristina, A., Saskia Harimurti, P., Regita Cendani, G., Azhar Insani, F., Erlina, L., Indah Paramita, R., & Fadilah, F. (2023). Virtual screening on Indonesian herbal compounds as SARS-CoV-2 spike (S2) glycoprotein inhibitors: Pharmacophore modeling and molecular docking approaches. Indonesian Journal of Medical Chemistry and Bioinformatics, 1(2).
Kumari, P., Singh, R., & Meena, A. (2023). Advances in molecular docking approaches for structure-based drug discovery. Current Computer-Aided Drug Design, 19(2), 85–101.
Morris, G. M., & Lim-Wilby, M. (2021). Molecular docking in modern drug discovery: principles and applications. Methods in Molecular Biology, 2266, 1–15.
Olaokun, O.O. (2023). Antidiabetic activity, molecular docking, and ADMET properties of compounds isolated from bioactive ethyl acetate fraction of Ficus lutea leaf extract.
Prasetio, NF, Bodhi, W., Manampiring, A., & Budiarso, F. (2021). Molecular docking of isoeleutherin and isoeleutherol compounds as inhibitors of SARS-CoV-2 growth. E-Biomedik, 9(1), 101–106.
Prayogi, S., Dhiani, BA, & Djalil, AD (2023). Molecular docking of bicycloproline derivative synthetic compounds on envelope protein: Anti-SARS-CoV-2 drug discovery. Indonesian Journal of Pharmacy and Pharmaceutical Sciences, 10(1), 11–21.
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2023). Current applications of molecular docking in drug discovery: a review. European Journal of Medicinal Chemistry, 243, 114744.
Sadiq, A. (2020). Eryngium caeruleum: In-vitro α-glucosidase, antioxidant, in-vivo antidiabetic and molecular docking-based approaches.
Sharma, A., Gupta, S., & Verma, R. (2021). Molecular interactions in drug–receptor complexes and their implications in drug design. Journal of Molecular Structure, 1245, 131024.
Sharon, F.B., & Kris, J.S. (2021). Molecular docking study on SARS-CoV-2 protease inhibition by exploring bioactive compounds from different plants. International Journal of Pharmaceutical Sciences and Research, 12(3), 1823–1833.
Siddique, A. (2022). Antidiabetic and antioxidant potentials of Abelmoschus esculentus: In vitro combined with molecular docking approach.
Torres, P. H. M., Sodero, A. C. R., Jofily, P., & Silva-Jr, F. P. (2022). Key topics in molecular docking for drug design. International Journal of Molecular Sciences, 23(6), 3380
Zabidi, N.A. (2021). Inhibitory evaluation of Curculigo latifolia on α-glucosidase, DPP-IV and in vitro studies in antidiabetic with molecular docking relevance to type 2 diabetes mellitus.